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ABSTRACT: NADPH oxidase 4 (Nox4) is constitutively active, while Nox2 requires the cytosolic regulatory
subunits p47
phox and p67
phox and activated Rac with activation by phorbol 12-myristate 13-acetate (PMA).
This study was undertaken to identify the domain on Nox4 that confers constitutive activity. Lysates from
Nox4-expressing cells exhibited constitutive NADPH- but not NADH-dependent hydrogen peroxide
production with a Km for NADPH of 55 ( 10 μM. The concentration of Nox4 in cell lysates was estimated
using Western blotting and allowed calculation of a turnover of ∼200 mol of H2O2 min
-1 (mol of Nox4)
-1.
A chimeric protein (Nox2/4) consisting of the Nox2 transmembrane (TM) domain and the Nox4 dehydro-
genase (DH) domain showed H2O2 production in the absence of cytosolic regulatory subunits. In contrast,
chimera Nox4/2, consisting of the Nox4 TM and Nox2 DH domains, exhibited PMA-dependent activation
that requiredcoexpression of regulatorysubunits. NoxDH domainsfrom several Nox isoforms werepurified
and evaluatedfortheir electron transferaseactivities. Nox1 DH, Nox2 DH, andNox5DHdomains exhibited
barely detectable activities toward artificial electron acceptors, while the Nox4 DH domain exhibited
significant rates of reduction of cytochrome c (160 min
-1, largely superoxide dismutase-independent),
ferricyanide (470 min
-1), and other electron acceptors (artificial dyes and cytochrome b5). Rates were similar
to those observed for H2O2 production by the Nox4 holoenzyme in cell lysates. The activity required added
FAD and was seen with NADPH but not NADH. These results indicate that the Nox4 DH domain exists
in an intrinsically activated state and that electron transfer from NADPH to FAD is likely to be rate-limiting
in the NADPH-dependent reduction of oxygen by holo-Nox4.
Reactive oxygen species (ROS),
1 which include superoxide
anion and its metabolites,are criticallyimportant both in phago-
cytic cells where they participate in killing bacteria and in other
cell types where they function as signaling molecules. A major
source of these biologically generated molecular species is the
reactive oxygen-generating NADPH oxidases or Nox enzymes.
The activation mechanisms of these enzymes differ among the
seven Nox isoforms (Nox1-5, Duox1, and Duox2) expressed in
humantissue.ThephagocyteNox, also known asthe respiratory
burst oxidase, has been extensively studied. The enzyme genera-
tes high levels of ROS in activated neutrophils and macrophages
and functions as a defense enzyme to kill invading microbes. The
oxidase consists of a membrane-associated catalytic subunit
Nox2 (also known as gp91
phox) that forms a heterodimer with
the small membrane subunit, p22
phox. Activation involves the
assembly of the membrane-bound heterodimer with cytosolic
regulatory subunits p47
phox,p 6 7
phox, and p40
phox and the GTP-
bound formof thesmallGTPaseRac (Rac1 or Rac2).The Nox2
catalytic subunit consists of two domains, a cytosol-facing
dehydrogenase (DH) domain that contains a binding site for
NADPH and one for FAD (1-3) and a membrane domain
consistingofsixtransmembrane(TM)helicesthatbindtwoheme
groups (hemes A and B) localized approximately at the levels of
thetwoleafletsofthemembranebilayer.Intheactivatedenzyme,
electrons pass from NADPH to the FAD and then through both
heme groups to reduce molecular oxygen to form the superoxide
transmembrane to the cytosol (i.e., either in the phagosome or
outside the cell). Evidence points to the DH domain of Nox2 as
the target of regulation by activator subunits (4, 5) and indicates
that the transfer of a hydride from NADPH to FAD is the rate-
determining step that is regulated by the “activation domain” on
p67
phox (6).
Regulated ROS production at considerably lower levels than
in neutrophils has been seen in a variety of nonphagocytic cells,
where it plays an important role in a range of physiological
processes. NADPH oxidase 1 (Nox1) is closely related to Nox2
(∼60% amino acid sequence identity) (7) and is expressed most
stronglyinthegastrointestinaltract(8,9)andinvascularsmooth
muscle exposed to angiotensin II (10, 11). Like Nox2, Nox1
activity is regulated by Rac, along with two regulatory subunits,
NOXO1andNOXA1(12-15),homologuesofp47
phoxandp67
phox,
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respectively. Nox3 is expressed in the inner ear (16) and is acti-
vated by NOXO1 (17-19). Nox4 is widely expressed, with its
strongest expression in the kidney (20, 21). While Nox1-3
comprise a close, evolutionarily related subgroup, Nox4 is more
distantlyrelated,with∼39% amino acididentity withNox2(21).
Like the Nox1-3 subfamily, Nox4 requires p22
phox for activity,
but unlike Nox1-3, Nox4 does not require the proline-rich
sequence in p22
phox that is the target of regulatory subunit
binding (22), consistent with its lack of a requirement for
regulatory subunits other than p22
phox (23, 24). Indeed, Nox4
is unique among the Nox enzymes in that it is constitutively
active (20, 25). In addition to the p22
phox-requiring Noxes,
mammals express the calcium-activated Nox enzymes Nox5,
Duox1, and Duox2, all of which possess an EF-hand-contining
Ca
2þ-binding domain (26-28).
Because expressed Nox4 does not require any known activa-
tors, regulatory subunits, or regulatory domains, we compared
the properties of Nox4 with those of other Nox homologues that
might account for its constitutive activity. Previous studies of
Nox2 pointed to the transfer of hydride from NADPH to FAD,
whichoccurswithintheDHdomain,astherate-determiningand
subunit-regulated step (4, 5). However, other studies suggested
that FAD-to-heme electron transfer may also be regulated in
Nox2 (29). Herein, we investigated the hypothesis that the con-
stitutive activityof Nox4 resides in its DH domain. This domain,
located immediately C-terminal to the TM domain, is homo-
logous to a number of soluble dehydrogenase-type flavoproteins
(1-3)andisthereforepredictedtoformanindependentlyfolding
DH domain that is localized at the cytosolic side of the
membrane. We find that the DH domain of Nox4 is constitu-
tively “turned on” compared with the DH domains of Nox1-3,
andthispropertyoftheDHdomainaccountsfortheconstitutive
activity of the holoenzyme.
MATERIALS AND METHODS
Materials. Full-length cDNA encodinghuman Nox4 (amino
acid residues 1-578) and cDNA of chimeric Noxes, Nox2/4
(residues 1-284 of Nox2 fused to residues 298-578 of Nox4),
and chimera Nox4/2 (residues 1-337 of Nox4 connected to
residues 324-570 of Nox2) were cloned into pcDNA3
(Invitrogen). cDNA encoding Nox DH domains (Nox1, -2, -4,
and-5)weresubclonedintopMAL-C2X(NewEnglandBiolabs).
DH domains corresponded to residues 283-570 for Nox1,
283-570 for Nox2, 304-578 for Nox4, and 405-737 for
Nox5. These constructs, producing MBP-tagged C-terminal
Nox homologues, were expressed in Escherichia coli BL-21.
The goat anti-rabbit IgG secondary antibody linked to horse-
radish peroxidase and prestained molecular weight markers for
SDS-PAGE were from Bio-Rad. The polyclonal antibody to a
C-terminal peptide (residues 500-578) of Nox4 was from Novus
Biologicals Inc., and the monoclonal antibody to MBP, amylose
agarose, and Factor Xa protease were from New England
Biolabs. Protease inhibitor cocktail was from Roche, and ferri-
cytochrome c, nitroblue tetrazolium (NBT), p-iodonitrotetrazo-
lium violet (INT), dichloroindophenol (DCIP), potassium
ferricyanide, FAD, NADPH, NADH, maltose, diphenyleneio-
donium (DPI),and proteinA-agaroseFastflow[50%(v/v)] were
purchased from Sigma Aldrich (St. Louis, MO).
Generation of cDNA Encoding a Nox2/4 Chimera.
Chimera Nox2/4 consists of the TM domain of Nox2 (residues
1-284) and the Nox4 DH domain (residues 298-578). Chimera
Nox4/2 consists of the Nox4 TM domain (residues 1-337) and
the Nox2 DH domain (residues 324-570). Chimeric constructs
were created by two consecutive PCRs. The following primers
were used to create Nox4/2: (1) human Nox4 sense primer with
the BamHI site underlined and with a kozak sequence, 50-tttt-
ggatccgccaccatggctgtgtcctggaggagctggctcgccaacga-30; (2) Nox4/2
sense primer with the Nox2 sequence underlined, 50-tttaaagcaa-
gacctggtcagtacatttttgtcaagtgccca-30; (3) Nox4/2 antisense primer
with the Nox2 sequence underlined (reverse complement of
primer 2), 50-tgggcacttgacaaaaatgtactgaccaggtcttgctttaaa-30; (4)
Nox2 antisense primer from the end of the sequence with the
NotI site underlined, 50-ttttgcggccgcttagaagttttccttgttgaaaatga-
aatgcac-30. The following primers were used to create chimera
Nox2/4: (5) human Nox2 sense primer with the BamHI site
underlined and with a kozak sequence, 50-ttttggatccaccAtggg-
gaactgggctgtgaatgaggggctc-30; (6) Nox2/4 sense primer with the
Nox2 sequence underlined, 50-ccatgtttctgtatctctgtgaaagacttta-
caggtatatccggagcaa-30; (7) Nox2/4 antisense primer with the
Nox2 sequence underlined, 50-ttgctccggatatacctgtaaagtctttc-
acagagatacagaaacatgg-30; (8) Nox4 antisense sequence with the
NotI site underlined, 50-ttttgcggccgcctagctgaaagactctttattgtattc-30.
PCRAusedprimers1and3toamplifyhumanNox4TMdomain
cDNA, primers 5 and 7 to amplify human Nox2 TM domain
cDNA,primers2and4toamplifyNox2DHdomaincDNA,and
primers 6 and 8 to amplify Nox4 DH domain cDNA. PCR B
used primers 1 and 4 to amplify PCR A products of Nox4 TM
and Nox2 DH domains and primers 5 and 8 to amplify PCR A
products of Nox2 TM and Nox4 DH domains. PCR products
from reaction B were digested with BamHI and NotI and ligated
into the mammalian expression vector, pcDNA3 (Invitrogen).
Sequences were confirmed by commercial DNA sequencing
(Agencourt Biosciences Corp.).
Transfection. HEK293 cells were cultured in Dulbecco’s
modifiedEagle’smedium(Gibco)containing4.6mg/mLglucose,
4.6 mg/mL L-glutamate, 10% fetal serum (Atlanta Biologicals),
100 units/mL penicillin, and 0.1 mg/mL streptomycin (Gibco) in
5% CO2 at 37 C for 24 h. Cells were transfected with cDNA
encoding human full-length Nox4, full-length Nox2, the Nox2/4
chimera, the Nox4/2 chimera in vector pcDNA3, or empty
pcDNA3 with and without co-expression of regulatory subunits
(human Rac1G12 V, p47
phox, and p67
phox), using the FuGene 6
(Roche Molecular Biochemicals) transfection system according
to the manufacturer’s instructions. After 48 h, cells were harves-
tedandwashedtwicewithHank’sbalancedsaltsolution(HBSS).
The cellspelleted at 2000g for 5 min weresuspendedin HBSS for
the NADPH oxidase assay of intact cells and in breaking buffer
for the cell-free oxidase assay.
Hydrogen Peroxide Generating Activity. Pyridine nucleo-
tide-dependent H2O2 producing activity was examined in intact
HEK293cellsandthecelllysates.Cells(∼2  10
7)i n2m Lo fi c e -
cold disruption buffer (PBS containing 0.1 mM EDTA, 10%
glycerol, 0.2 mM FAD, 1 μg/mL protease inhibitor cocktail, and
0.1 mM PMSF) were disrupted bysonication (2   10 s) ina bath
sonicator at 3 C, according to the previously described meth-
ods (30). ROS generation was assessed by either Luminol chemi-
luminescence increase using a FluoStar luminometer (BMG
Labtech)orthefluorescenceincreaseat620nmwithabandwidth
of 40 nm (excitation wavelength of 540 nm with a bandwidth of
25 nm) due to H2O2-dependent Amplex Red oxidation in the
presence of HRP using a Synergy 2 Multi-Mode Microplate
Reader and Gen5 (Bio Tek). A standard curve of known H2O2
concentrations was developed using the Amplex Red assay and
wasusedtoquantifyH2O2concentration.Inthewholecellassay,Article Biochemistry, Vol. 49, No. 11, 2010 2435
5-7   10
4 cells were added to 0.1 mL of assay buffer [25 mM
Hepes (pH 7.4) containing 0.12 M NaCl, 3 mM KCl, 1 mM
MgCl2,0.1mMAmplexRed,and0.032unitofHRP].Inthecell-
freeassay,thereactionwasstartedviaadditionofanappropriate
amount (30-50 μg of protein) of the cell lysates to 0.1 mL of the
assay mixture (assay buffer containing 25 μM FAD and 36 μM
NADPH or 36 μM NADH). The reaction was monitored at
25 C for 10 min, and the emissionincreasewaslinear duringthis
interval. Reaction rates determined in the cell lysates were
normalized to 10
7 cells on the basis of the total protein equiva-
lents, 4.53 mg/10
7 cells for vector-transfected cell lysates and
4.16 mg/10
7 cells for Nox4-transfected cell lysates.
Spectrophotometric Measurements of Heme in Cell Ex-
tracts of HEK293. Whole cell extracts were prepared using the
Nonidet P-40 lysis buffer according to a previously described
method (31). Cells were incubated for 30 min in ice-cold Nonidet
P-40 lysis buffer [50mM Tris-HCl (pH 7.5), 0.12 M NaCl,5 mM
EDTA, 5 mM EGTA, 1% Nonidet P-40, and 5% glycerol].
Lysates were centrifuged at 14000g for 20 min, and the super-
natant was collected. The extracts of HEK293 cells transfected
with vector alone or vector encoding Nox4 were used for the
quantification ofheme.Reducedspectrawererecordedat10min
intervalsafteradditionofafewcrystalsofsodiumdithioniteuntil
a stable spectrum was achieved. A molar absorption coefficient
(ε414)o f1 3 0m M
-1 cm
-1 (32) for the Soret band was used for
calculations.
ExpressionofNox1,Nox2,Nox4,andNox5DHDomains.
AseriesoftruncatedNoxcloneswasobtainedbyPCRusingeach
Nox cDNA cloned in the pMAL-C2X plasmid as the template.
According to previously described methods (4), PCR products
for truncated Nox1 DH (residues 283-570), Nox2 DH (residues
283-570), Nox4 DH (residues 304-578), and Nox5 DH (resi-
dues 405-737) domains were purified using a PCR purification
kit (Qiagen). The purified DNA fragments were ligated into the
EcoRI and SalI sites for the Nox1 DH domain, BamHI and
HindIII for the Nox2 DH domain, and BamHI and SalI for
Nox4 DH and Nox5 DH domains in pMAL-C2X vector and
transformed into E. coli. Transformants were selected from LB/
ampicillin plates, and plasmids were isolated from 2 mL cultures
of transformants as described previously (4). The plasmids were
digested with restriction enzymes and were separated on 1%
agarose to confirm the presence of the insert. DNA sequences of
all clones were confirmed by nucleotide sequencing.
Expression and Purification of Nox DH Proteins. MBP
fusion proteins were induced in E. coli at 37 Cb ya d d i t i o no f
0.1 mM IPTG for 2.5 h and frozen at -80 C. Thawed cells were
sonicated (3   15 s) and solubilized in 50 mM Hepes buffer (pH
7.5) containing 0.5 M NaCl, 1 mM PMSF, 1 mM EDTA, 1 mM
dithiothreitol, protease inhibitor cocktail (1 μg/mL), and 0.2 M
L-arginine at 3 C. Arginine was included to improve the yield
and minimize protein aggregation (33). Purification was con-
ducted by amylose-agarose column chromatography (10 mm  
15 mm) according to instructions from BioLabs, and the fusion
proteins were stored at -80 C in 50 mM Hepes buffer (pH 7.5)
containing 0.1 M NaCl, 0.2 M arginine, 1 mM EDTA, 0.2%
Tween20,proteaseinhibitorcocktail,and0.1mMPMSF.Long-
term storage was avoided due to gradual proteolysis and loss of
activity.
Superoxide Generating Activity. Superoxide generation
was assessed using SOD-inhibitable ferricytochrome c reduction
quantifiedat550nmusinganextinctioncoefficientof21.1mM
-1
cm
-1 (34). The indicated amount of HEK293 cell lysate or
isolated Nox DH domain protein was added to 1 mL of assay
buffer [25 mM Hepes (pH 7.3) containing 0.25 mM FAD,
0.1 mM ferricytochrome c, 0.1 M NaCl, 3 mM KCl, 1 mM MgCl2,
and 0.1 mM PMSF], after which 0.2 mM NADPH or 0.2 mM
NADH was added, and cytochrome c reduction was monitored
in the presence and absence of 100 units of SOD at 36 C.
Pyridine Nucleotide-Dependent Electron Transferring
Activity. NADPH-dependent cytochrome c, cytochrome b5,
ferricyanide [K3Fe(CN)6], DCIP, INT, and NBT reductase
activitieswereassayed at36Caccordingtopreviouslydescribed
methods (4). The activities were assayed in a 1 mL volume of
assay buffer [25 mM Hepes buffer (pH 7.3) containing 0.12 M
NaCl, 3 mM KCl, 1 mM MgCl2,0 . 2 5m MF A D ,a n d8 0μM
electron acceptor]. After the mixture that included the DH
domain had been preincubated for 1 min, the reaction was
initiated by the addition of 0.25 mM NADPH or 0.25 mM
NADH. A longer preincubation did not affect activity. The
reduction rates of electron acceptors were quantified by mon-
itoring the absorbance changes at the appropriate wavelengths,
andmillimolarextinctioncoefficientsof21.1mM
-1cm
-1at550nm
(cytochrome c)( 34), 19 mM
-1 cm
-1 at 556 nm (cytochrome
b5)( 35),1.02mM
-1cm
-1at420nm(ferricyanide)(36),20mM
-1
cm
-1 at 600 nm (DCIP) (37), 10.5 mM
-1 cm
-1 at 490 nm
(INT)(38),and12.6mM
-1cm
-1at595nm(NBT)(39)wereused
to calculate the quantity of each electron acceptor reduced.
SpectrophotometricmeasurementsweretakenusingusingaHitachi
spectrophotometer with a temperature-controlled cuvette com-
partment.
Immunoprecipitation and Western Blot Analysis. Nox4
protein was immunoprecipitated from lysates of HEK293 cells
and detected by Western blotting. Whole cell extracts were
prepared using the Nonidet P-40 lysis buffer as described above.
Celllysates(0.85mg) fromvectoraloneorNox4-transfectedcells
were first precleared with 10 μL of protein A-agarose Fast Flow
beads (50% slurry) for 1 h. The supernatant was incubated with
20μg of antibody toNox4and 20μL ofproteinA-agarosebeads
overnight with gentle shaking at 4 C. The beads were washed
threetimeswithlysisbuffer,andboundproteinswereelutedfrom
the beads into 50 μL of Laemmli sample buffer (Bio-Rad). After
SDS-PAGE and after immunoprecipitated proteins had been
transferred to an Immobilon PVDF membrane (Millipore),
Nox4 was visualized using the same antibody with a horseradish
peroxidase-linked secondary antibody (IgG, 1:3000 dilution).
Proteins were visualized by chemiluminescence (SuperSignal
West Pico Chemiluminescence Substrate, Pierce) or using 3,30-
diaminobenzidine stain (Dojindo). Quantification of immuno-
precipitated Nox4 was performed using a standard curve pro-
duced with the purified MBP-bound Nox4 DH domain. The
integral optical density (IOD) of the Western blot band was esti-
mated using ImageJ.
RESULTS
Pyridine Nucleotide Specificity and Properties of Nox4
Expressed in a Broken Cell Preparation. The Nox2 cell-free
system from neutrophil or macrophage cell fractions has been
invaluable for the characterization of the enzymatic properties
and regulation of the Nox2 system. Lacking an adequate cell
that expresses high levels of endogenous Nox4, we used Nox4-
transfected versus vector-transfected control cells to characterize
Nox4 properties. Hydrogen peroxide and superoxide generation
were compared in intact cells and cell lysates using the Amplex
Red/HRPassayandcytochromecreduction,respectively.Asshown2436 Biochemistry, Vol. 49, No. 11, 2010 Nisimoto et al.
in Table 1, intact Nox4-expressing HEK293 cells showed >20-
fold higher H2O2 generating activity than control cells, and 98%
of the Nox4-dependent activity was inhibited with 20 μMD P I .
Nearly 70% of the Nox4-dependent activity was retained in the
cell lysate when NADPH wasusedas the electron donor, andthe
majority of this activity was inhibited with DPI. Minimal Nox4-
dependent activity was seen when NADH was used as the elec-
tron donor, confirming that the enzyme is specific for NADPH.
Consistentwithearlierreports(40-42),H2O2butnotsuperoxide
was detectable in Nox4-transfected cells on the basis of the ab-
sence of detectable SOD-sensitive cytochrome c reduction (data
not shown).
As shown in the Lineweaver-Burk plot (Figure 1A), the Km
value of Nox4 for NADPH was determined to be 55 ( 10 μM, a
value close to that previously reported for Nox2 (∼50 μM) (43).
Activity required added FAD, but increasing FAD concentra-
tions from 20 to 75 μM did not further stimulate the maximal
activity [360 pmol min
-1 (10
7 cells)
-1]o rc h a n g et h eKm for
NADPH (Figure 1A). Thus, holo-Nox4 is fully saturated at
25 μM FAD added to the cell-free assay system.
Determination of the Turnover Number of Nox4 in Cell
Lysates. In cell extracts, we detected a major band of ∼75 kDa
and a minor band at ∼130 kDa by immunoprecipitation and
Western blot analysis using an antibody to a C-terminal Nox4
peptide (Figure 1C). A weaker endogenous 75 kDa band was
seen in the extracts from control cells (Figure 1B). The Nox4
content in the lysates was estimated using the purified recombi-
nant MBP-Nox4 DH domain fusion protein as a standard
(Figure1D,E)tobe0.38pmol/mgofextractprotein,correspond-
ing to approximately 1.6 pmol of Nox4 per 10
7 cells. This
represents only ∼5% of the level of Nox2 that is constitutively
expressedinneutrophils(∼35 pmol/10
7cells)(44-46).Assuming
most of the Nox4 was immunoprecipitated and neglecting the
contribution of the minor 140 kDa band, we found the estimated
turnover of Nox4 to be 230 min
-1. Spectrophotometric analysis
(datanot shown) showed an increased heme contentof0.9pmol/
mg in Nox4-transfected compared with control cells. Using this
estimate, a similar turnover number was calculated.
ROS Generation by Nox2, Nox4, and Nox2/4 and Nox4/2
Chimeric Proteins in HEK293 Cells. Nox2 activation is depen-
dent on the assembly of cytosolic regulatory subunits, p67
phox,
p47
phox, and the GTP-bound form of Rac, while Nox4 activity
requires none of these additional proteins (20, 47, 48). To deter-
mine whether it is the TM domain or the DH domain that is
responsibleforconferringthecytosolicsubunit-dependentversus
constitutive activity, we created chimeric proteins by switching the
TMand DHdomains ofNox2and Nox4as showninFigure2A.
The cDNA encoding wild-type or chimeric proteins was ex-
pressed either without or with p67
phox,p 4 7
phox, and Rac1G12V
inHEK293cells,andtheresultingROSgeneratingactivitieswere
measured (Figure 2B). As in previous studies (20, 25), wild-type
Nox4 exhibited constitutive activity that was unaffected by
subunits,whileNox2activityrequiredcoexpressionofregulatory
subunits. Like wild-type Nox4, chimera Nox2/4 ROS generating
activity was constitutively active and was independent of regu-
latory subunits or PMA stimulation. In contrast, chimera Nox4/2,
likewild-typeNox2,displayedactivityonlyuponcoexpressionof
subunits and stimulation with PMA. Therefore, the Nox2 DH
domain contains the determinants that are the target of regula-
tory subunit binding and regulation, while the structural features
necessaryforconstitutiveactivityresideintheNox4DHdomain.
Electron Transferase Activity of Nox DH Domains. Experi-
ments conducted with chimeric proteins indicated that the Nox4
DH domain is necessary to observe the constitutive activity of
Nox4.Todeterminewhetherthisdomainwassufficienttoexhibit
spontaneous electron transferase activity, the Nox4 DH domain
was expressed and purified as an MBP fusion protein and elec-
tron transferase activity toward several artificial electron accep-
torswasmeasured.Forcomparison,Nox1,Nox2,andNox5DH
domains were also expressed and purified. MBP-Nox DH
domain fusion proteins corresponded in size to their predicted
molecular masses on SDS-PAGE (Figure 3A) and were recog-
nizedon Westernblots using an anti-MBPantibody(Figure3B).
The MBP-fused forms of the Nox DH domains were used in this
studybecause of the poorsolubilityofthe DH domains when the
MBP tag was omitted or cleaved. Figure 4 shows the NADPH-
dependent electron transferase activity of each isolated Nox DH
domain, assayed using cytochrome c, cytochrome b5,f e r r i c y a -
nide, DCIP, INT, or NBT as an electron acceptor. The MBP-
Nox4 DH domain fusion protein showed significant NADPH-
dependent electron transferase activity toward both one-electron
acceptors and two-electron accepting dyes, and turnover num-
bers varied somewhat according to the electron acceptor emp-
loyed, with ferricyanide being the best electron accepting substrate
Table 1: Hydrogen Peroxide Generating Activity (picomoles per minute per 10
7 cells) of HEK293 Cells Expressing Nox4
a
intact cell assay control (a) Nox4 (b) b - a (%)
HEK293 cells 10.2(2.5 225.9(30.0 215.7(100)
with DPI 0.85 (0.2 4.84(1.0 4.00(1.9)
NADPH NADH
cell-free assay control (a) Nox4 (b) b - a (%) control (a) Nox4 (b) b - a (%)
cell lysate 74.0(6.3 223.5(18.5 149.5 (69.3) 117.0(25.1 141.4( 12.2 24.4(13)
with DPI 49.2(5.6 101.3(15.2 52.1(24.2) 78.5(10.3 91.3( 7.8 12.8(5.9)
aIntheintactcellassay,thereactionwasinitiatedbyadditionof5μLofcells(5-7 10
4)to95μLofassaybuffer(pH7.5)containing25mMHepes,120mM
NaCl, 3 mM KCl, 1 mM MgCl2, 0.032 unit of HRP, and 0.1 mM Amplex Red. The fluorescence of Amplex Red was measured for 10 min at 25 C. In the cell-
free oxidase assay, NADPH- or NADH-dependent H2O2 generation by cell lysates was monitored in 0.1 mL of the same buffer containing 25 μM FAD and
36 μM NADPH or 36 μM NADH. We initiated the reaction by mixing 30-50 μg of the sample/5 μL of lysate with 95 μL of the assay buffer in the presence or
absenceof20μMDPI.Asacontrol,5μLofthecelllysisbufferwasaddedto95μLofthereactionmixtureinsteadofthecelllysates.Thedifferencebetweenthe
fluorescence in thepresenceand absence of thesamplewas measured, and the activity (picomolesof H2O2produced perminuteper 10
7cells or milligrams)was
calculated using a linear standard curve of the fluorescence intensity vs H2O2 concentration (nanomolar). Thecell lysates from 10
7 cells transfected with vector
alone (control) or Nox4 contained 4.53 ( 0.35 or 4.16 ( 0.30 mg of protein, respectively. Values represent the means ( the standard deviation of three
experiments.Article Biochemistry, Vol. 49, No. 11, 2010 2437
(470 min
-1), followed by DCIP (180 min
-1), cytochrome c
(160 min
-1), INT (95 min
-1), cytochrome b5 (75 min
-1), and
NBT (65 min
-1, the least active). The high rate seen with
ferricyanide istypicalof manyflavoproteindehydrogenases,pre-
sumably due to the favorable access of this small chelated iron
acceptor to the FAD. In contrast to the cytochrome c reductase
activity of the intact Nox2 system, Nox4 DH domain reduction
of this substrate was largely unaffected by added SOD (data not
shown) and is therefore due to a direct electron transfer from the
enzyme FAD rather than a superoxide-mediated reaction. In
contrast, Nox1, Nox2, and Nox5 DH domains exhibited only
very low NADPH-dependent electron transferase rates (<1 min
-1),
regardlessofthe electronacceptor(Figure4),andnoactivitywas
observed using NADH as the electron donor (data not shown).
Previously, we reported that the presence of activating subunits
stimulated diaphorase activity of the Nox2 DH domain (4). The
turnover,however,wasstillverylow( <10min
-1)c o m p a r e dw i t h
that seenwith Nox4. MBP alone showed no activity, and MBP-
Nox4 DH domain activity was inhibited by 70% or more with
DPI for all electron acceptors. Little or no Nox4 DH domain-
dependent activity was observed in the absence of added FAD,
indicating loss of FAD during the purification. For all electron
acceptors, Nox4 DH domain-dependent activities were very low
using NADH rather than NADPH as an electron donor
FAD and NADPH Concentration-Dependent Electron
Transferase Activities of Nox2 DH and Nox4 DH Domains.
Cytochrome c reduction provided a convenient assay with which
to determine kinetic parameters of the Nox4 DH domain. The
EC50 of the FAD for activation of Nox4 DH domain-dependent
cytochrome c reduction was 65 ( 10 μM [Figure 5A (b)]. In
contrast, FAD failed to stimulate the activity of the Nox2 DH
domain up to 0.3 mM [Figure 5A (O)]. The Km for NADPH for
the Nox4 DH domain was 20 ( 5 μM (Figure 5B). In addition,
DPI inhibited NADPH-specific cytochrome c reductase activity
of the Nox4 DH domain in a concentration-dependent manner,
but rotenone, used as a negative control, did not (Figure 5C).
DISCUSSION
The functional role of the DH domain of Nox enzymes, aside
from binding FAD and NADPH, is to catalyze the transfer of
reducing equivalents from NADPH through FAD to the heme
iron of flavocytochrome b558.N o x 1 -4 form a heterodimer with
the p22
phoxsubunitthat isessential for their catalytic activity and
structural stability. Unlike Nox4, Nox1-3 require additional
FIGURE 1: Nox4-dependent hydrogen peroxide generation in HEK293 cell lysates. (A) Hydrogen peroxide production by cell lysates was
measured in the presence of various concentrations of FAD: 20 (b), 25 (O), 50 (2), and 75 μM( 4). The rate was determined at various
concentrationsofNADPH,andadouble-reciprocalplotofinitialvelocityvsNADPHconcentrationwasusedtoestimateKmandVmaxvaluesat
each concentration of FAD. The reaction velocity (v) due to the overexpressed Nox4 was determined by subtracting the activity of the empty
vector-transfectedcellsasinTable1.Thedataarerepresentativeofthreeseparateexperiments.(BandC)ExpressionofNox4proteininHEK293
cells. Extracts (0.85 mg of protein) from both empty vector-transfected cells (B) and Nox4 cDNA-transfected cells (C) were subjected to
immunoprecipitation using an antibody to Nox4. Lanes 1-3 contained 3, 6, and 10 μL, respectively, of SDS sample buffer containing proteins
immunoprecipitatedwithproteinA-agarosebeadsFastFlow[50%(v/v)].SDS-PAGE(7.5%)followedbyWesternblottingwasusedtovisualize
Nox4 protein. The 50 kDa band indicated by an arrow is the IgG heavy chain. (D) Immunoblot of the purified MBP-Nox4 DH domain fusion
protein.Inlanes1-6,0.012-0.075pmolofpurifiedMBP-Nox4DHdomainfusionproteinwasapplied.(E)Thestandardcurvewasobtainedby
plotting the amount of MBP-Nox4 DH domain fusion protein loaded vs the IOD (integral optical density) of the band visualized in panel
D. Filled circles show data for the standard MBP-Nox4 DH domain fusion protein, while the empty circle indicates the IOD and determined
Nox4 content of the 75 kDa holo-Nox4 band in lane 3 in panel C. The experiment shown is representative of three.2438 Biochemistry, Vol. 49, No. 11, 2010 Nisimoto et al.
regulatorysubunitswhileNox5,Duox1,andDuox2areactivated
by their calcium-binding regulatory domains. The constitutive
activity of Nox4 is independent of known regulatory subunits
or domains, and features of its structure are therefore expected
toresembletheactivatedstatethatisachievedintheotherNoxor
Duox proteins in response to regulatory protein-protein inter-
actions.Ourpreviousstudies(4,5)ofNox2DHdomain-p67
phox
interaction and indirect evidence from X-linked CGD muta-
tions(49,50)indicatedthatbindingofp67
phoxtoNox2stimulates
the flowof electrons from NADPHtoFAD (51, 52).Our studies
were based on the ability of phagocyte oxidase regulatory
subunits to stimulate a low rate of NADPH-dependent dye
reduction activity by the Nox2 DH domain. In support of this
interpretation, our Nox4/2 chimera (see Figure 2) is inactive in
the basal state but is activated to near wild-type activity by
subunits with PMA. In contrast, like wild-type Nox4, the reverse
chimera Nox2/4 shows constitutive activity that is unaffected by
regulatorysubunitcotransfection or PMA.Consistentwiththese
data, a recent study reported constitutive activity by a Nox1/4
chimera (Nox1 TM and Nox4 DH) that was independent of the
Nox1 regulatory subunits NOXO1 and NOXA1 (40). In con-
trast, a study published as this work was being completed (53)
reported that a Nox2/4 chimera was inactive. The reason for this
discrepancy may be that the chimera junctions (i.e., the amino
acid boundary where the sequence changes from the Nox2 TM
domain to the Nox4 DH domain) are not the same between our
Nox2/4chimera(whichendstheNox2TMdomainataminoacid
284 and begins the Nox4 DH domain at amino acid 298) and the
Nox2/4 chimera reported in the recent study (53) (which ends
the Nox2 TM domain at amino acid 290 and begins the Nox4
DH domain at amino acid 304). We have made several Nox2/4
chimeras with slightly different junctions, and we find that small
differences in position at which the DH domain begins can
drastically decrease or eliminate activity (data not shown). Thus,
both our study and the earlier studies of the Nox1/4 chimera
supporttheideathattheDHdomainratherthantheTMdomain
is a major determinant of the overall activity and is the target for
regulation by activating subunits.
To further explore this hypothesis and determine whether the
DHdomainisnotonlynecessarybutalsosufficientfordetermin-
ing the overall activity, we expressed the DH domains from
Nox1, Nox2, Nox4, and Nox5 and investigated their intrinsic
activity toward nonphysiological dyes or proteins. The steps in
electron transfer that occur within the Nox DH domain are an
initial two-electron transfer from NADPH to FAD with sub-
sequentone-electrontransfersfromthereducedandsemiquinone
flavin to heme. In these experiments, the heme-containing TM
domain is replaced with exogenous hemoproteins (cytochrome
candcytochromeb5lackingthehydrophobicmembrane-anchor-
ing domain), the small iron-containing ferricyanide, or various
dyes. The midpoint redox potentials of these acceptors ranged
from 20 mV for soluble cytochrome b5 to 360 mV for ferricya-
nide, all significantly higher than the redox potential of the FAD
of known flavoprotein dehydrogenases (54-56). No correlation
between the reduction rate and redox potential of the electron
acceptor was seen, indicating that other factors (e.g., the reduc-
tion of the FAD, steric access of the electron acceptor to the
FAD,etc.)aremoreimportantinthedeterminationoftheoverall
rate. While the DH domains from Nox1, Nox2, and Nox5
exhibited very low activity (<1 min
-1), the Nox4 DH domain
showed significant rates of electron transfer (65-470 min
-1
depending on the electron acceptor), and these activities were
inhibitedby DPI. The mostrapid rateof reduction was seen with
ferricyanideasanelectronacceptor,aphenomenonthathasbeen
observed with many flavoprotein dehydrogenases and which is
often taken to be a measure of the rate of reduction of the FAD
(34, 57, 58). The rapid reduction may be permitted due to the
small size of this acceptor (allowing close approach to the redu-
ced FAD), the very positive redox potential, and/or additional
FIGURE 2: ROS generationofNox4/2and Nox2/4chimericproteins
and regulation by phox regulatory subunits. (A) Schematic model of
Nox2/4and Nox4/2chimeric proteinsshowing Nox2TM/Nox4 DH
and Nox4 TM/Nox2 DH, respectively. (B) cDNA encoding Nox4
(wildtype),Nox2(wildtype),Nox2/4,Nox4/2,oremptyvectoralone
(mock) was transfected with or without coexpression of cytosolic
subunitproteins(p67
phox,p4 7
phox,andRac1G12V) inHEK293cells.
ROS production was measured by Luminol chemiluminescence in
the oxidase assay buffer in the absence (white bars) and presence
(black bars) of PMA at 37 C. Three separate transfection experi-
mentswereconducted,andtheactivityisshownasmeanrelativelight
units (RLUs) ( the standard deviation (n=3).
FIGURE 3: Isolated dehydrogenase domains of Nox homologues.
(A) MBP fusion forms of Nox1 DH, Nox2 DH, Nox4 DH, and
Nox5DHdomainpurifiedproteins(∼4.5μg) wereloadedontoa10%
(w/v) SDS-PAGE gel and stained with Coomassie brilliant blue.
(B) Nox-DH proteins (∼1.2 μg) were subjected to 10% SDS-PAGE,
followed by immunoblotting using an anti-MBP antibody.Article Biochemistry, Vol. 49, No. 11, 2010 2439
unknown factors. For NADPH-dependent cytochrome c reduc-
tase activity, which is often used as a readout for superoxide
generation, there was no significant decrease in activity in the
presence of SOD, indicating that the DH domain of Nox4 gene-
rates little if any superoxide. Rather, the reduction of this hemo-
protein must occur directly from reduced forms of the enzyme-
bound FAD. Therefore, in this setting, cytochrome c provides a
model for the endogenous NADPH-to-FAD-to-heme reduction
that occurs in the holoenzyme. In previous studies, we were able
to show an increase in the rate of NADPH-dependent reduction
ofartificialelectronacceptorscatalyzedbytheNox2DHdomain
as a result of addition of the Rac-p67
phox complex, pointing to
the DH domain as the locus of regulation in Nox2 (4).
A consistent picture showing that properties of the DH domain
determine the overall rate of electron transfer through the Nox
catalytic units during the generation of reactive oxygen species
emerges from this study and earlier studies. This is in accord with
earlier studies (5) which pointed to the transfer of hydride from
NADPH to FAD to form FADH2 as the rate-determining step in
Nox2, a step that is regulated by the activation domain of p67
phox.
In addition, during turnover of activated Nox2, FAD is main-
tained in a mostly oxidized (∼70%) form, while heme remains
almost entirely oxidized, again indicating that in the activated
enzyme,FAD reduction is the rate-limitingstep.Whilethis type of
experiment is not feasible with Nox4 due to low expression levels,
these studies are consistent with this model for Nox4 activity. The
correspondence in turnover number of intact Nox4 during the
NADPH-dependent formation of hydrogen peroxide (200 min
-1)
and NADPH-dependent electron transfer rates to artificial sub-
strates (65-470 min
-1) strongly suggests that FAD reduction
represents the rate-determining step in holo-Nox4.
As a reflection of earlier uncertainties about the pyridine
nucleotide specificity of novel Noxenzymes,the classofenzymes
has previously been termed NAD(P)H oxidases (note paren-
theses). Sumimoto and colleagues (21) reported that the specifi-
city of Nox4 was for NADH, while Serrander and colleagues
reportedspecificityforNADPH(41).Usingourlysedcellsystem,
thisstudy showsa clear specificity of Nox4 for NADPH, and the
Km of 55 ( 10 μM is nearly the same as that reported for the
phagocyte oxidase (Nox2) cell-free system (43). The expressed
and purified Nox4 DH domain also shows a nearly complete
preferenceforNADPHoverNADH.Therefore,weproposethat
for Nox4, the terminology NAD(P)H oxidase be abandoned
in favor of NADPH oxidase. We suggest that the somewhat
lower Km of the Nox4 DH domain for NADPH of 20 ( 5 μM
(Figure 5B) reflects a somewhat lessefficient transfer of electrons
fromFADtothehemeofcytochromeccomparedwiththenative
heme A, which would result in a lower Km based solely on the
combinationofkineticconstantsthatgovernKm[i.e.,(k2þk-1)/k1]
that yield a higher Km value when k2 islarger.Comparison ofthe
activity in intact cells versus cell lysates also indicated that most
of the Nox4 activity was recovered in broken cell preparations.
In addition, the activity appears to be relatively stable to storage
at 4 C (data not shown).
Whileappreciable,the turnovernumberforNox4 inthe trans-
fectedcellsystemisconsiderablylowerthanthatofthephagocyte
enzyme, which has been reported to be >5000 min
-1. It is possi-
ble that the lower turnover is an artifact of the overexpression
systemandthatonlyafractionofexpressedNox4isactuallyactive.
While this cannot be rigorously ruled out at present, the lower
rate is also consistent with respective biological functions, with
Nox2 being optimized for high activity to generate bactericidal
FIGURE 4: Pyridinenucleotide-dependentelectrontransferaseactivitiesofNox1DH,Nox2DH,Nox4DH,andNox5DHdomains.Isoformsof
the MBP-fused Nox DH domain (∼25 μg) and MBP alone were assayed for cytochrome c, cytochrome b5, ferricyanide, DCIP, INT, and NBT
reductase activities.The assay was initiatedvia additionof0.25mMNADPH or0.25mMNADHto1 mLof25mMHepes (pH7.3) containing
0.12MNaCl,3mMKCl,1mMMgCl2,proteaseinhibitorcocktail(1μg),0.25mMFAD,and80μMelectronacceptor.NADPHwasusedinall
the experiments, except where NADH is indicated in the third bar of each figure. The NADPH-dependent reductive reaction of Nox4-DH was
conductedwithout(firstcolumn)orwith(secondcolumn)20μMDPIpreincubatedat36Cfor30s.Eachreductiveactivityindicatestheturnover
number mean of three independent assays, with the error bars showing the standard deviation.2440 Biochemistry, Vol. 49, No. 11, 2010 Nisimoto et al.
quantities of ROS and Nox4 requiring lower activity to generate
signaling levels of H2O2. Alternatively, the rate observed may
represent a low basal rate that can be further stimulated by
unknown regulatory factors that are not present in the HEK293
cells. For example, in a recent study, the p22
phox-binding protein
Poldip2 produced a modest stimulation of Nox4 activity in rat
smoothmusclecells,althoughitnotclearwhetherthiswasdueto
activation or protein stabilization (59).
In summary, the implication of this study is the Nox4 DH
domain exists in a conformation that allows the spontaneous
transfer of electronsfromNADPHtoFAD, and thispropertyof
the DH domain explains the constitutive activity of Nox4.
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